Search research articles
Contact Us
Filters
Showing results (181-190 of 208) with videos related to
Page
of 21
Sort By:
Diabetes, Metabolic Syndrome and Obesity : Targets and Therapy
|
January 1, 2014
TRC210258, a novel TGR5 agonist, reduces glycemic and dyslipidemic cardiovascular risk in animal models of diabesity
Shitalkumar P Zambad, Davinder Tuli, Anoop Mathur, et al.
Cancers
|
August 7, 2021
Targeted Oral Delivery of Paclitaxel Using Colostrum-Derived Exosomes
Raghuram Kandimalla, Farrukh Aqil, Sara S Alhakeem, et al.
Circulation. Heart Failure
|
April 9, 2013
Chronic therapy with a partial adenosine A1-receptor agonist improves left ventricular function and remodeling in dogs with advanced heart failure
Hani N Sabbah, Ramesh C Gupta, Smita Kohli, et al.
Journal of Cardiac Failure
|
July 10, 2013
Effects of acute intravenous infusion of apelin on left ventricular function in dogs with advanced heart failure
Mengjun Wang, Ramesh C Gupta, Sharad Rastogi, et al.
Diabetes, Metabolic Syndrome and Obesity : Targets and Therapy
|
March 31, 2011
TRC150094 attenuates progression of nontraditional cardiovascular risk factors associated with obesity and type 2 diabetes in obese ZSF1 rats
Shitalkumar P Zambad, Siralee Munshi, Amita Dubey, et al.
Carcinogenesis
|
June 15, 2012
Controlled-release systemic delivery - a new concept in cancer chemoprevention
Ramesh C Gupta, Shyam S Bansal, Farrukh Aqil, et al.
Cancer Letters
|
February 17, 2017
Exosomal formulation of anthocyanidins against multiple cancer types
Radha Munagala, Farrukh Aqil, Jeyaprakash Jeyabalan, et al.
Cancer Letters
|
February 21, 2021
Exosome-mediated delivery of RNA and DNA for gene therapy
Radha Munagala, Farrukh Aqil, Jeyaprakash Jeyabalan, et al.
Journal of Clinical Rheumatology : Practical Reports on Rheumatic & Musculoskeletal Diseases
|
July 24, 2015
Efficacy and Safety of Tabalumab, an Anti-B-Cell-Activating Factor Monoclonal Antibody, in a Heterogeneous Rheumatoid Arthritis Population: Results From a Randomized, Placebo-Controlled, Phase 3 Trial (FLEX-O)
Mark C Genovese, Gregg J Silverman, Paul Emery, et al.
Bioorganic & Medicinal Chemistry Letters
|
December 23, 2008
Synthesis of spiro[chroman-2,4'-piperidin]-4-one derivatives as acetyl-CoA carboxylase inhibitors
Pundlik Shinde, Sanjay K Srivastava, Rajendra Odedara, et al.
Page
of 21
Search research articles
Search
Showing results (181-190 of 208) with videos related to
Sort By:
Page
of 21
Diabetes, Metabolic Syndrome and Obesity : Targets and Therapy
|
January 1, 2014
TRC210258, a novel TGR5 agonist, reduces glycemic and dyslipidemic cardiovascular risk in animal models of diabesity
Shitalkumar P Zambad, Davinder Tuli, Anoop Mathur, et al.
Cancers
|
August 7, 2021
Targeted Oral Delivery of Paclitaxel Using Colostrum-Derived Exosomes
Raghuram Kandimalla, Farrukh Aqil, Sara S Alhakeem, et al.
Circulation. Heart Failure
|
April 9, 2013
Chronic therapy with a partial adenosine A1-receptor agonist improves left ventricular function and remodeling in dogs with advanced heart failure
Hani N Sabbah, Ramesh C Gupta, Smita Kohli, et al.
Journal of Cardiac Failure
|
July 10, 2013
Effects of acute intravenous infusion of apelin on left ventricular function in dogs with advanced heart failure
Mengjun Wang, Ramesh C Gupta, Sharad Rastogi, et al.
Diabetes, Metabolic Syndrome and Obesity : Targets and Therapy
|
March 31, 2011
TRC150094 attenuates progression of nontraditional cardiovascular risk factors associated with obesity and type 2 diabetes in obese ZSF1 rats
Shitalkumar P Zambad, Siralee Munshi, Amita Dubey, et al.
Carcinogenesis
|
June 15, 2012
Controlled-release systemic delivery - a new concept in cancer chemoprevention
Ramesh C Gupta, Shyam S Bansal, Farrukh Aqil, et al.
Cancer Letters
|
February 17, 2017
Exosomal formulation of anthocyanidins against multiple cancer types
Radha Munagala, Farrukh Aqil, Jeyaprakash Jeyabalan, et al.
Cancer Letters
|
February 21, 2021
Exosome-mediated delivery of RNA and DNA for gene therapy
Radha Munagala, Farrukh Aqil, Jeyaprakash Jeyabalan, et al.
Journal of Clinical Rheumatology : Practical Reports on Rheumatic & Musculoskeletal Diseases
|
July 24, 2015
Efficacy and Safety of Tabalumab, an Anti-B-Cell-Activating Factor Monoclonal Antibody, in a Heterogeneous Rheumatoid Arthritis Population: Results From a Randomized, Placebo-Controlled, Phase 3 Trial (FLEX-O)
Mark C Genovese, Gregg J Silverman, Paul Emery, et al.
Bioorganic & Medicinal Chemistry Letters
|
December 23, 2008
Synthesis of spiro[chroman-2,4'-piperidin]-4-one derivatives as acetyl-CoA carboxylase inhibitors
Pundlik Shinde, Sanjay K Srivastava, Rajendra Odedara, et al.
Page
of 21